Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Oct 13, 2017 7:46am
457 Views
Post# 26808475

RE:RE:RE:RE:PROMETIC ANNOUNCES FDA ACCEPTANCE OF ITS BIOLOGICS LICENSE A

RE:RE:RE:RE:PROMETIC ANNOUNCES FDA ACCEPTANCE OF ITS BIOLOGICS LICENSE AThis is THE best case scenario playing out!

The BLA acceptance and PDUFA date issuance is a huge milestone and de risker,  the analysts and institutions will be all over this.  All the worry and Rumour momgering on the street about a rejection letter and other BS is completely dispelled with this news.

the PDUFA date represents the absolute “end date” meaning the FDA will Render its decision  between now and then.  Given how supportive the FDA has been with the Fast track designation and the Pediatric Designation, smart money will be betting on an formal approval in the next 60-90 days... and very likely to include a Pediatric Voucher

This is a smart money catalyst, analysts and institutions will be all over this today.  Expect a big up move on  big volume.  Have fun, and stay long its just beginning
Bullboard Posts